1. Peppard PE, Young T, Palta M et al. Prospective study of the association between sleep–disordered breathing and hypertension. N Engl J Med 2000; 342: 1378–1384.
2. NIH Consensus Conference. Impotence. NIH Consensus Development Panel on Impotence. Jama 1993; 270: 83–90.
3. Garban H, Marquez D, Cai L et al. Restoration of normal adult penile erectile response in aged rats by long–term treatment with androgens. Biol Reprod 1995; 53: 1365–1372.
4. Dahiya R, Lin A, Bakircioglu ME et al. mRNA and protein expression of nitric oxide synthase and adrenoceptor alpha 1 in young and old rat penile tissues. Br J Urol 1997; 80: 300–306.
5. Carrier S, Nagaraju P, Morgan DM, Baba K, Nunes L, Lue TF. Age decreases nitric oxide synthase-containing nerve fibers in the rat penis. J Urol 1997; 157: 1088–1092.
6. Haas CA, Seftel AD, Razmjouei K et al. Erectile dysfunction in aging: upregulation of endothelial nitric oxide synthase. Urology 1998; 51: 516–522.
7. Johannes CB, Araujo AB, Feldman HA et al. Incidence of erectile dysfunction in men 40 to 69 years old: longitudinal results from the Massachusetts male aging study. J Urol 2000; 163: 460–463.
8. Melman A, Gingell JC. The epidemiology and pathophysiology of erectile dysfunction. J Urol 1999; 161: 5–11.
9. Saenz de Tejada I, Goldstein I. Diabetic penile neuropathy. Urol Clin North Am 1988; 15: 17–22.
10. Saenz de Tejada I, Goldstein I, Azadzoi K et al. Impaired neurogenic and endothelium-mediated relaxation of penile smooth muscle from diabetic men with impotence. N Engl J Med 1989; 320: 1025–1030.
11. Azadzoi KM, Saenz de Tejada I. Diabetes mellitus impairs neurogenic and endothelium-dependent relaxation of rabbit corpus cavernosum smooth muscle. J Urol 1992; 148: 1587–1591.
12. Vernet D, Cai L, Garban H et al. Reduction of penile nitric oxide synthase in diabetic BB/WORdp (type I) and BBZ/WORdp (type II) rats with erectile dysfunction. Endocrinology 1995; 136: 5709–5717.
13. Sullivan ME, Bell CR, Dashwood MR et al. Autoradiographic localization of nitric oxide synthase binding sites in normal and diabetic rat corpus cavernosum. Eur Urol 1996; 30: 506–511.
14. Elabbady AA, Gagnon C, Hassouna MM et al. Diabetes mellitus increases nitric oxide synthase in penises but not in major pelvic ganglia of rats. Br J Urol 1995; 76: 196–202.
15. Seftel AD, Vaziri ND, Ni Z et al. Advanced glycation end products in human penis: elevation in diabetic tissue, site of deposition, and possible effect through iNOS or eNOS. Urology 1997; 50: 1016–1026.
16. Azadzoi KM, Goldstein I. Erectile dysfunction due to atherosclerotic vascular disease: the development of an animal model. J Urol 1992; 147: 1675–1681.
17. Azadzoi KM, Park K, Andry C et al. Relationship between cavernosal ischemia and corporal veno-occlusive dysfunction in an animal model. J Urol 1997; 157: 1011–1017.
18. Azadzoi KM, Goldstein I, Siroky MB et al. Mechanisms of ischemia-induced cavernosal smooth muscle relaxation impairment in a rabbit model of vasculogenic erectile dysfunction. J Urol 1998; 160: 2216–2222.
19. Mannino DM, Klevens RM, Flanders WD. Cigarette smoking: an independent risk factor for impotence? Am J Epidemiol 1994; 140: 1003–1008.
20. Xie Y, Garban H, Ng C et al. Effect of long–term passive smoking on erectile function and penile nitric oxide synthase in the rat. J Urol 1997; 157: 1121–1126.
21. Young T, Palta M, Dempsey J et al. The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med 1993; 328: 1230–1235.
22. Tishler PV, Larkin EK, Schluchter MD et al. Incidence of sleep-disordered breathing in an urban adult population: the relative importance of risk factors in the development of sleep-disordered breathing. JAMA 2003; 289: 2230–2237.
23. Kára T, Souček M. Autonomní nervový systém. In: Souček M, Kára T. Klinická patofyziologie hypertenze. Praha: Grada 2002: 37–99.
24. Chobanian AV, Bakris GL, Black HR et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003; 289: 2560–2572.
25. Kára T, Souček M, Kárová Š et al. Metabolický kardiovaskulární syndrom a sympatický nervový systém: je obstrukční spánková apnoe klíčem k pochopení? Vnitř Lék 2005; 51(1): 53–61.
26. Arruda–Olson AM, Olson LJ, Nehra A et al. Sleep apnea and cardiovascular disease. Implications for understanding erectile dysfunction. Herz 2003; 28: 298–303.
27. Hirshkowitz M, Karacan I, Arcasoy MO et al. Prevalence of sleep apnea in men with erectile dysfunction. Urology 1990; 36: 232–234.
28. Bassiri A, Guillerminault C. Clinical features and evaluation of obstructive sleep apnea-hypopnea syndrome. In: Kriger M, Roth T, Dement W. Principles and practice of sleep medicine. Philadelphia:
Saunders 2000: 869–878.
29. Schmidt HS, Wise HA. Significance of impaired penile tumescence and associated polysomnographic abnormalities in the impotent patient. J Urol 1981; 126: 348–352.
30. Fanfulla F, Malaguti S, Montagna T et al. Erectile dysfunction in men with obstructive sleep apnea: an early sign of nerve involvement. Sleep 2000; 23: 775–781.
31. Luboshitzky R, Herer P, Levi M et al. Relationship between rapid eye movement sleep and testosterone secretion in normal men. J Androl 1999; 20: 731–737.
32. Phillips BG, Narkiewicz K, Pesek CA et al. Effects of obstructive sleep apnea on endothelin-1 and blood pressure. J Hypertens 1999; 17: 61–66.